We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
161 hedge funds and large institutions have $554M invested in Anika Therapeutics in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 46 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
246% more call options, than puts
Call options by funds: $6.59M | Put options by funds: $1.91M
33% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 46
24% more capital invested
Capital invested by funds: $446M → $554M (+$108M)
4.42% less ownership
Funds ownership: 94.54% → 90.12% (-4.4%)
5% less funds holding
Funds holding: 170 → 161 (-9)
30% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 27
Holders
161
Holders Change
-9
Holders Change %
-5.29%
% of All Funds
3.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
61
Reduced
46
Closed
27
Calls
$6.59M
Puts
$1.91M
Net Calls
+$4.68M
Net Calls Change
+$1.11M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$6.17M |
| 2 |
EC
Engaged Capital
Newport Beach,
California
|
+$4.91M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$3.38M |
| 4 |
BlackRock
New York
|
+$3.1M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.8M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$16.5M |
| 2 |
Bank of New York Mellon
New York
|
-$8.61M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.98M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$5.72M |
| 5 |
First Manhattan
New York
|
-$3.27M |
